| Mapping genomic loci implicates genes and synaptic biology in schizophrenia V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ... Nature 604 (7906), 502-508, 2022 | 1115 | 2022 |
| SynGO: an evidence-based, expert-curated knowledge base for the synapse F Koopmans, P van Nierop, M Andres-Alonso, A Byrnes, T Cijsouw, ... Neuron 103 (2), 217-234. e4, 2019 | 556 | 2019 |
| Calmodulin dependence of presynaptic metabotropic glutamate receptor signaling V O'Connor, OE Far, E Bofill-Cardona, C Nanoff, M Freissmuth, ... Science 286 (5442), 1180-1184, 1999 | 195 | 1999 |
| On the structure of the ‘synaptosecretosome’ Evidence for a neurexin/synaptotagmin/syntaxin/Ca2+ channel complex VM O'Connor, O Shamotienko, E Grishin, H Betz FEBS letters 326 (1-3), 255-260, 1993 | 186 | 1993 |
| SNAP-mediated protein–protein interactions essential for neurotransmitter release WM DeBello, V O'connor, T Dresbach, SW Whiteheart, SSH Wang, ... Nature 373 (6515), 626-630, 1995 | 176 | 1995 |
| Ca2+ or Sr2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin M Capogna, RA McKinney, V O’Connor, BH Gähwiler, SM Thompson Journal of Neuroscience 17 (19), 7190-7202, 1997 | 174 | 1997 |
| Clostridial neurotoxins compromise the stability of a low energy SNARE complex mediating NSF activation of synaptic vesicle fusion. LL Pellegrini, V O'Connor, F Lottspeich, H Betz The EMBO journal 14 (19), 4705-4713, 1995 | 157 | 1995 |
| The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective VH Perry, V O'Connor ASN neuro 2 (5), AN20100024, 2010 | 152 | 2010 |
| Synaptic vesicle exocytosis: molecules and models V O'Connor, GJ Augustine, H Betz Cell 76 (5), 785-787, 1994 | 141 | 1994 |
| Fluensulfone is a nematicide with a mode of action distinct from anticholinesterases and macrocyclic lactones J Kearn, E Ludlow, J Dillon, V O’Connor, L Holden-Dye Pesticide Biochemistry and Physiology 109, 44-57, 2014 | 139 | 2014 |
| Subfield‐specific immediate early gene expression associated with hippocampal long‐term potentiation in vivo PJ French, V O'Connor, MW Jones, S Davis, ML Errington, K Voss, ... European Journal of Neuroscience 13 (5), 968-976, 2001 | 133 | 2001 |
| The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in Caenorhabditis elegans M Guest, K Bull, RJ Walker, K Amliwala, V O’Connor, A Harder, ... International journal for parasitology 37 (14), 1577-1588, 2007 | 130 | 2007 |
| Disruption of syntaxin-mediated protein interactions blocks neurotransmitter secretion V O’Connor, C Heuss, WM De Bello, T Dresbach, MP Charlton, JH Hunt, ... Proceedings of the National Academy of Sciences 94 (22), 12186-12191, 1997 | 129 | 1997 |
| Regulation of neurotransmitter release kinetics by NSF FE Schweizer, T Dresbach, WM DeBello, V O'Connor, GJ Augustine, ... Science 279 (5354), 1203-1206, 1998 | 115 | 1998 |
| Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping Z Šišková, A Page, V O’Connor, VH Perry The American journal of pathology 175 (4), 1610-1621, 2009 | 106 | 2009 |
| SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming A Burgalossi, S Jung, G Meyer, WJ Jockusch, O Jahn, H Taschenberger, ... Neuron 68 (3), 473-487, 2010 | 104 | 2010 |
| C1q: the perfect complement for a synaptic feast? VH Perry, V O'connor Nature Reviews Neuroscience 9 (11), 807-811, 2008 | 104 | 2008 |
| Latrotoxin receptor signaling engages the UNC-13-dependent vesicle-priming pathway in C. elegans J Willson, K Amliwala, A Davis, A Cook, MF Cuttle, N Kriek, NA Hopper, ... Current Biology 14 (15), 1374-1379, 2004 | 90 | 2004 |
| Synaptopathy: dysfunction of synaptic function? N Brose, V O'connor, P Skehel Biochemical Society Transactions 38 (2), 443-444, 2010 | 89 | 2010 |
| Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology BC Gray, Z Siskova, VH Perry, V O'Connor Neurobiology of disease 35 (1), 63-74, 2009 | 88 | 2009 |
